Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Graz, Graz, Austria.
Field of Excellence BioHealth, University of Graz, Graz, Austria.
Immunology. 2024 Oct;173(2):286-295. doi: 10.1111/imm.13773. Epub 2024 Mar 11.
Inflammation is initiated and driven by a mixture of mediators, which modify effects of each other. This study analysed in vitro pro-inflammatory activity of inflammatory cytokines (TNFα and IL-1β) in a combination with a lipid DAMP molecule, oxidized palmitoyl-arachidonoyl-phosphatidylcholine (OxPAPC). The study was performed on endothelial and monocytic cell lines. The cells were treated with different concentrations of TNFα or IL-1β, OxPAPC and their combinations, either in the presence or absence of drugs regulating inflammation. Pro-inflammatory effects of TNFα/IL-1β and OxPAPC were estimated by analysis of chemokines CXCL8, CXCL2 and CXCL3 by ELISA and RT-PCR. Toxicity was determined by analysis of metabolic activity. Statistical significance was estimated by ANOVA and Dunnett's test. OxPAPC was a much weaker chemokine inducer as compared to TNFα or IL-1β. However, OxPAPC and TNFα/IL-1β together induced effects that were significantly stronger than the arithmetical sum of individual effects. This cooperative action of OxPAPC and TNFα was reversed by inhibitors of p38 MAPK. We hypothesise that the boosting of TNFα and IL-1β effects by OxPAPC may be more pathologically important than the action of the lipid alone. Inhibitors of p38 MAPK may become a tool for analysis of pathological role of oxidized phospholipids.
炎症是由多种介质引发和驱动的,这些介质相互作用并改变彼此的效应。本研究分析了炎症细胞因子(TNFα 和 IL-1β)与脂质 DAMPs 分子氧化棕榈酰-花生四烯酸-磷酸胆碱(OxPAPC)联合的体外促炎活性。该研究在血管内皮细胞和单核细胞系上进行。细胞分别用不同浓度的 TNFα 或 IL-1β、OxPAPC 及其混合物处理,同时存在或不存在调节炎症的药物。通过 ELISA 和 RT-PCR 分析趋化因子 CXCL8、CXCL2 和 CXCL3,评估 TNFα/IL-1β 和 OxPAPC 的促炎作用。通过分析代谢活性来确定毒性。通过方差分析和 Dunnett 检验估计统计学意义。与 TNFα 或 IL-1β 相比,OxPAPC 是一种较弱的趋化因子诱导剂。然而,OxPAPC 和 TNFα/IL-1β 联合诱导的效应明显强于单个效应的算术和。OxPAPC 和 TNFα 之间的这种协同作用被 p38 MAPK 抑制剂逆转。我们假设 OxPAPC 增强 TNFα 和 IL-1β 效应的作用可能比脂质本身的作用更具病理性意义。p38 MAPK 抑制剂可能成为分析氧化磷脂病理性作用的工具。